Paula Olsiewski, PhD
Paula J. Olsiewski, Ph.D. joined the Alfred P. Sloan Foundation as a Program Director in 2000. Dr. Olsiewski created and directs the Foundation’s programs in Microbiology of the Built Environment and Synthetic Biology, for which grantmaking was concluded in 2014. Dr. Olsiewski led Sloan’s Biosecurity program until its conclusion in 2010. She also oversees the Sloan Public Service Awards, the Foundation’s Civic Initiatives, and the Sloan Awards for Excellence in Teaching Science and Mathematics.
Dr. Olsiewski serves on numerous advisory committees and boards, including serving as the Chair of the Board of Scientific Counselors Homeland Security Research Subcommittee at the U.S. Environmental Protection Agency. She previously served on the advisory board for the National Consortium for the Study of Terrorism and Responses to Terrorism (START), a Center of Excellence of the U.S Department of Homeland Security based at the University of Maryland (2005- 2012). She served on the Board of Advisors for the WMD Center’s Bio-Response Report Card in 2011 and was a member of the NRC Committee on Advances in Technology and the Prevention of their Application to Next Generation Biowarfare Threats, which produced the “Globalization, Biosecurity, and the Future of Life Sciences” report (2006).
Dr. Olsiewski serves as Board Chair of the Dominican Friars Health Care Ministry of New York. She also is a board member of the Spondylitis Association of America and is the Yale Alumni Fund Co-Chair of Agents for the Class of 1975. She was a member of the MIT Corporation (2003-2009), was President of the MIT Alumni Association (2003-2004), and served on the MIT Initiative on Faculty Race and Diversity Advisory Committee (2008-2009). Dr. Olsiewski also was a member of the Board of Trustees of Asphalt Green, Inc. (1997-2009) and served at Board Chair (2000-2005). Dr. Olsiewski has received awards for fundraising from Yale, MIT, and Asphalt Green.
Prior to joining the Foundation, Dr. Olsiewski served in many capacities in the biotech and biomedical community. She directed the New York City Biotechnology Initiative, a state-funded program under the auspices of the New York Biotechnology Association, to improve the region’s ability to grow biotechnology companies by fostering relationships between academia and industry. She established and directed the technology licensing office at the Hospital for Special Surgery, an affiliate of Weill Medical College of Cornell University. Dr. Olsiewski has served as a consultant on numerous projects, providing technical analysis of biomedical companies and technologies for investment banking groups and state economic development agencies. She worked for nine years at Enzo Biochem, Inc., a publicly traded biotechnology company, where she directed commercial development activities for a variety of in vitro diagnostic products.
Dr. Olsiewski received a Bachelor of Science in chemistry from Yale College and a Doctorate in biological chemistry from MIT.